Exagen
Yahoo Finance • 12 months ago
Exagen Inc. Reports Strong Third Quarter 2023 Results
SAN DIEGO, California, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2023. Recognized total revenue... Full story
Yahoo Finance • 12 months ago
Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers
SAN DIEGO, California, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, and Johns Hopkins University jointly announced today the execution of an exclusive license agreement.... Full story
Yahoo Finance • last year
Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
SAN DIEGO, California, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Heal... Full story
Yahoo Finance • last year
Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting
SAN DIEGO, California, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the acceptance of five abstracts at the 2023 American College of Rheumatology’s (ACR... Full story
Yahoo Finance • last year
Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
SAN DIEGO, California, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the 2023 Cantor Fitzgerald Global Healthcare Conference, which... Full story
Yahoo Finance • last year
Exagen (NASDAQ:XGN) shareholders are up 20% this past week, but still in the red over the last three years
Exagen Inc. (NASDAQ:XGN) shareholders will doubtless be very grateful to see the share price up 43% in the last month. But only the myopic could ignore the astounding decline over three years. To wit, the share price sky-dived 73% in that... Full story
Yahoo Finance • last year
Exagen Inc. Reports First Quarter 2023 Results
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN)("Exagen"), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2023. First Quarter Highlights: Deliv... Full story
Yahoo Finance • last year
Mindera Health™ Announces Change to Executive Leadership Team
San Diego, CA, May 11, 2023 (GLOBE NEWSWIRE) -- Mindera Health™, the developer of Mind.Px™, the first realization of precision medicine in psoriasis, has announced a change in its executive leadership team. The company has announced ind... Full story
Yahoo Finance • 2 years ago
Q4 2022 Exagen Inc Earnings Call
Participants John Aballi; CEO, President & Director; Exagen Inc. Kamal Adawi; CFO & Corporate Secretary; Exagen Inc. Ryan Douglas; Investors Relations Officer; Exagen Inc. Andrew Frederick Brackmann; Research Analyst; William Blair & C... Full story
Yahoo Finance • 2 years ago
Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
SAN DIEGO, March 20, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full year ended December 31, 2022. Recent Highlight... Full story
Yahoo Finance • 2 years ago
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023
SAN DIEGO, March 06, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter and year ended December 31, 2022, after the market close on Monda... Full story
Yahoo Finance • 2 years ago
Exagen Inc. to Participate in Upcoming March Conferences
SAN DIEGO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that management will participate in the following March investor conferences. Cowen 43rd Annual... Full story
Yahoo Finance • 2 years ago
Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
SAN DIEGO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference... Full story
Yahoo Finance • 2 years ago
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
Exagen Inc. SAN DIEGO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Tina S. Nova, Ph.D. has been elected as Executive Chair of the Exagen Board of Di... Full story
Yahoo Finance • 2 years ago
Exagen Inc. Reports Third Quarter 2022 Results
SAN DIEGO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2022. Third Quarter Highlights: Total reve... Full story
Yahoo Finance • 2 years ago
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
SAN DIEGO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that management will participate in the following fourth quarter investor conferences. Canaccord... Full story
Yahoo Finance • 2 years ago
Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022
Exagen Inc. SAN DIEGO, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended September 30, 2022, after the market close on Mon... Full story
Yahoo Finance • 2 years ago
Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RA
SAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the launch of a prospective clinical study designed to validate a novel and minimally invasive ge... Full story
Yahoo Finance • 2 years ago
Exagen Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference
SAN DIEGO, July 25, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Canaccord Genuity 42nd Annual Growth Conference, which takes place Augus... Full story
Yahoo Finance • 2 years ago
Exagen to Announce Second Quarter 2022 Financial Results on August 4, 2022
SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended June 30, 2022, after the market close on Thursday, August 4,... Full story
